Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3

BACKGROUND: Allergen immunotherapy (SIT) is the only treatment for allergic disease capable of modifying disease long term. To reduce the risk of anaphylaxis from SIT, allergen-extracts have been modified by polymerisation with glutaraldehyde to reduce IgE binding. It is suggested that these allergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Urry, Zoe L, Richards, David F, Black, Cheryl, Morales, Maria, Carnés, Jerónimo, Hawrylowicz, Catherine M, Robinson, Douglas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051145/
https://www.ncbi.nlm.nih.gov/pubmed/24884430
http://dx.doi.org/10.1186/1471-2172-15-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051145/
https://www.ncbi.nlm.nih.gov/pubmed/24884430
http://dx.doi.org/10.1186/1471-2172-15-21

Ejemplares similares